Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
UTHR
UTHR
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
UTHR News
United Therapeutics Reports Positive Phase 1 Results for MiroliverELAP
Jan 26 2026
Benzinga
United Therapeutics Upgraded to Overweight with Price Target of $535.73
Jan 06 2026
Yahoo Finance
WYNN Options Volume Surges 148.3% with 19,101 Contracts Traded
Dec 31 2025
NASDAQ.COM
S&P 500 Futures Steady in Pre-Market Session; United Therapeutics and Intel Underperform
Dec 24 2025
Barron's
IJK Shares Near 52-Week High of $99.90, Last Trade at $99.22
Dec 22 2025
NASDAQ.COM
Significant Options Trading on Wednesday: UTHR, URGN, DSGN
Dec 17 2025
NASDAQ.COM
Insider at United Therapeutics Offloads Shares Valued at $3,952,689, Recent SEC Filing Reveals
Dec 16 2025
Yahoo Finance
Significant Withdrawals Observed in ETF for SPMD, COHR, LITE, UTHR
Dec 05 2025
NASDAQ.COM
Younger Investors Continue to Favor Sustainable Investing: Insights from an Expert's Selections.
Dec 01 2025
Barron's
Significant Options Activity on Tuesday: UTHR, GOOGL, META
Nov 25 2025
NASDAQ.COM
Reevaluating United Therapeutics (UTHR) Valuation Following Significant Share Price Increases
Nov 23 2025
Yahoo Finance
Significant ETF Withdrawals: IJH, FLEX, UTHR, COHR
Nov 20 2025
NASDAQ.COM
Electric plane manufacturer backed by GE and Amazon experiences high demand for its IPO
Nov 04 2025
MarketWatch
RBC Capital Reaffirms Outperform Rating for United Therapeutics and Increases Price Target to $587
Oct 30 2025
Benzinga
Transcript of Earnings for United Therapeutics (UTHR)
Oct 30 2025
NASDAQ.COM
Wells Fargo Keeps Equal-Weight Rating on United Therapeutics, Increases Price Target to $423
Oct 30 2025
Benzinga
Show More News
